Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Circulation
|
May 15, 1995
Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study
F V Aguirre, L T Younis, B R Chaitman, et al.
Journal of the American College of Cardiology
|
November 13, 2001
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial
W B Batchelor, K W Mahaffey, P B Berger, et al.
Circulation
|
July 1, 1997
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators
R Q Migrino, J B Young, S G Ellis, et al.
Journal of the American College of Cardiology
|
October 1, 1992
Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 Investigators
J L Anderson, L C Becker, S G Sorensen, et al.
Circulation
|
November 15, 1996
Evolution of early TIMI 2 flow after thrombolysis for acute myocardial infarction. GUSTO-1 Angiographic Investigators
J S Reiner, C F Lundergan, A Fung, et al.
Journal of the American College of Cardiology
|
December 1, 1996
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience
S L Woodfield, C F Lundergan, J S Reiner, et al.
Journal of the American College of Cardiology
|
December 10, 1999
A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial
A M Ross, K S Coyne, J S Reiner, et al.
Circulation
|
March 7, 1998
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators
S G Goodman, A Langer, A M Ross, et al.
American Heart Journal
|
June 30, 2001
Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experience
C F Lundergan, A M Ross, W F McCarthy, et al.
Circulation
|
May 21, 1998
Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial
A M Ross, K S Coyne, E Moreyra, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Circulation
|
May 15, 1995
Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study
F V Aguirre, L T Younis, B R Chaitman, et al.
Journal of the American College of Cardiology
|
November 13, 2001
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial
W B Batchelor, K W Mahaffey, P B Berger, et al.
Circulation
|
July 1, 1997
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators
R Q Migrino, J B Young, S G Ellis, et al.
Journal of the American College of Cardiology
|
October 1, 1992
Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 Investigators
J L Anderson, L C Becker, S G Sorensen, et al.
Circulation
|
November 15, 1996
Evolution of early TIMI 2 flow after thrombolysis for acute myocardial infarction. GUSTO-1 Angiographic Investigators
J S Reiner, C F Lundergan, A Fung, et al.
Journal of the American College of Cardiology
|
December 1, 1996
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience
S L Woodfield, C F Lundergan, J S Reiner, et al.
Journal of the American College of Cardiology
|
December 10, 1999
A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial
A M Ross, K S Coyne, J S Reiner, et al.
Circulation
|
March 7, 1998
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators
S G Goodman, A Langer, A M Ross, et al.
American Heart Journal
|
June 30, 2001
Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experience
C F Lundergan, A M Ross, W F McCarthy, et al.
Circulation
|
May 21, 1998
Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial
A M Ross, K S Coyne, E Moreyra, et al.
Page
of 14